Table 7.
Clinicopathological characteristics of SRCC according to ESD indication.
| Yes (n = 38) | No (n = 22) | P | |
|---|---|---|---|
| Sex | |||
| Male | 23 (60.5%) | 11 (50%) | |
| Female | 15 (39.5%) | 11 (50%) | 0.428 |
| Age (years) | |||
| <65 | 31 (81.6%) | 15 (68.2%) | |
| ≥65 | 7 (18.4%) | 7 (31.8%) | 0.237 |
| Macroscopic type | |||
| IIa | 1 (2.6%) | 0 (0%) | |
| IIb | 16 (42.1%) | 4 (18.2%) | |
| IIc | 20 (52.6%) | 10 (45.5%) | |
| III | 0 (0%) | 8 (36.4%) | |
| IIa+IIc | 1 (2.6%) | 0 (0%) | <0.001 |
| Pure/mixed | |||
| Pure | 31 (81.6%) | 12 (54.5%) | |
| Mixed | 7 (18.4%) | 10 (45.5%) | 0.025 |
| LNM | |||
| (+) | 2 (5.3%) | 4 (18.2%) | |
| (-) | 36 (94.7%) | 18 (81.8%) | 0.179 |
ESD, endoscopic submucosal dissection; SRCC, signet ring cell carcinoma.